Selected research from leading health care experts whose findings have a direct bearing on public policies effecting medical progress. Research is chosen based on its quality and relevance by the Medical Progress Today editorial staff.

Selected Research

The Impact of New Drug Launches on Longevity
Joseph Calfee, Ph.D., NBER Working Paper No. w9754, 6-1-03

Given the high cost of health care, especially for new medicines, we can often lose sight of the "big-picture": medical progress brings benefits to society, including increased productivity, decreased mortality, and improved human health. As a result, it is critical to remind ourselves that medical innovation has quantifiable benefits. Using an econometric analysis of data from the leading source of global drug data and the WHO Mortality database for 52 countries, this study finds that launches of "new chemical entities" (NCEs) leads to increased survival rates. Indeed, NCE launches accounted for 40% of the total increase in human longevity between 1986 and 2000.

Project FDA.
home   spotlight   commentary   research   events   news   about   contact   links   archives
Copyright Manhattan Institute for Policy Research
52 Vanderbilt Avenue
New York, NY 10017
(212) 599-7000